Covid-19 Variant PJ.2.1 Accounts for Growing Share
The variant, first identified in North America in May, has spread rapidly across continents and carries many spike-protein mutations.
Updated on Nov. 11, 2026 in COVID-19

Live Poll
Are you worried about new Covid variants affecting you personally right now?
The PJ.2.1 variant of Covid-19 is accounting for a greater proportion of cases, having achieved rapid intercontinental spread since it was first identified in North America in May. It has been detected in Ontario, Canada, New York, US, Australia, Singapore and Spain.
Why it matters
PJ.2.1 binds to the ACE2 receptor more effectively than other variants, which may help explain its rapid spread worldwide. Global case counts have nonetheless declined significantly, and the variant's broader impact remains under study.
Reported global totals stand at about 780 million Covid-19 infections and about 7 million deaths, while the number of new cases has declined significantly. The precise share of cases attributable to PJ.2.1 has not been quantified in the available data.
The details
PJ.2.1 carries many mutations on its spike protein and binds to ACE2, the receptor the virus uses to enter cells, more effectively than other variants. It is not thought to be better at evading the human immune system, and projections suggest it may cause more severe throat infections and prolonged fatigue, though these outcomes cannot be predicted with certainty.
Timeline
May 2026: PJ.2.1 identified in North America and Ontario, Canada.
End of June 2026: PJ.2.1 detected in New York, US.
September 2026: Chinese scientists released a study on the variant's rapid intercontinental spread.
Health Landscape
PJ.2.1's rapid spread runs counter to the broader decline in new Covid-19 case numbers seen in recent periods, making it a localized rise within an overall downward trajectory. Its more effective binding to ACE2 offers a mechanistic explanation that researchers are weighing against the variant's wider epidemiological footprint.
Reported symptoms for PJ.2.1 may include more severe throat infections and prolonged fatigue, which could affect daily routines for those who contract it. Individuals experiencing persistent symptoms should consult a healthcare provider for guidance on treatment and recovery.
The takeaway
Tracking how variants spread and bind to human cells helps explain why some strains move faster across borders than others. Staying informed through official health guidance remains the most reliable way to understand changing risks.
Further reading
Explore more on the COVID-19 section for context on how variants like PJ.2.1 are tracked and studied.
Source note: This article includes information reported by Juta MedicalBrief.
Live Poll
Are you worried about new Covid variants affecting you personally right now?







